Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Angina IV: Management01:26

Angina IV: Management

10
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
10
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Self-Assembly of Antigenic Peptide Nanofibrils Templates the Growth of Silica Nanoparticles for Nanovaccines.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Environment-enabled fault diagnosis system for photovoltaic power stations.

The Review of scientific instruments·2026
Same author

Utilizing biological responses to evaluate the In vivo fate and biocompatibility of reduced graphene oxide-integrated nerve guidance conduits for peripheral nerve repair.

Biomedical materials (Bristol, England)·2026
Same author

Inhibition of Ice Recrystallization by Regulating the Surface Free Energy of Nanoparticles.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Predicting major adverse cardiovascular and cerebrovascular events in chronic heart failure: a machine learning study.

Annals of medicine·2026
Same author

Anaerobic metabolic evolution for homotypic L-valine fermentation.

Nature communications·2026

Related Experiment Video

Updated: Jul 13, 2025

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

27.8K

New treatment methods for myocardial infarction.

Bingbing Sun1, Long Wang2, Wenmin Guo1

  • 1Department of Critical Care Medicine, The Air Force Characteristic Medical Center, Air Force Medical University, Beijing, China.

Frontiers in Cardiovascular Medicine
|October 16, 2023
PubMed
Summary

Cardiac regenerative medicine offers new hope for heart attack recovery. Cardiac tissue engineering aims to regenerate damaged heart muscle, addressing limitations of current treatments for heart failure after myocardial infarction.

Keywords:
cardiac regenerative medicinecoronary heart diseaseexosomemyocardial infarctionscaffold

More Related Videos

Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.6K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.3K

Related Experiment Videos

Last Updated: Jul 13, 2025

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

27.8K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

13.6K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.3K

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Biomedical Engineering

Background:

  • Coronary atherosclerotic cardiovascular disease and acute myocardial infarction have high morbidity and mortality.
  • Current treatments for myocardial ischemia-reperfusion do not target infarcted myocardium, leading to increasing heart failure rates.
  • Acute myocardial infarction mortality decline contributes to a higher incidence of heart failure.

Purpose of the Study:

  • To explore cardiac tissue engineering as an innovative therapy for myocardial infarction.
  • To discuss the advantages and challenges of cardiac tissue engineering for myocardial regeneration.
  • To provide a reference for clinical treatment of heart failure after myocardial infarction.

Main Methods:

  • Review of research on elements for myocardial regeneration (cells, scaffolds, cytokines).
  • Analysis of contemporary innovative therapies for myocardial infarction.
  • Evaluation of cardiac tissue engineering approaches.

Main Results:

  • Cardiac regenerative medicine provides a promising new therapeutic option.
  • Cardiac tissue engineering research has identified key elements for myocardial regeneration.
  • Existing therapies have limitations in addressing myocardial pathological remodeling and function reduction.

Conclusions:

  • Cardiac tissue engineering presents a novel approach to improve cardiac function post-myocardial infarction.
  • Understanding the components of cardiac regeneration is crucial for future research.
  • Cardiac tissue engineering offers hope for preventing and treating heart failure.